Apomorphine in the Treatment of Parkinson’s Disease
Apomorphine is a dopamine agonist used in the treatment of some motor and non-motor complications during Parkinson’s disease, which could be administered as an intermittent or continuous infusion. Although apomorphine treatment has been shown to be effective on motor fluctuations and dyskinesias, th...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2021-12-01
|
| Series: | Türk Nöroloji Dergisi |
| Subjects: | |
| Online Access: | https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-06706&look4= |
| _version_ | 1797909649576427520 |
|---|---|
| author | Serhat Özkan |
| author_facet | Serhat Özkan |
| author_sort | Serhat Özkan |
| collection | DOAJ |
| description | Apomorphine is a dopamine agonist used in the treatment of some motor and non-motor complications during Parkinson’s disease, which could be administered as an intermittent or continuous infusion. Although apomorphine treatment has been shown to be effective on motor fluctuations and dyskinesias, there is no sufficient consensus regarding the administration of apomorphine test or infusion, and the management of the treatment. In this review, our aim is to create a “treatment management guideline,” which includes recommendations for the use of apomorphine in the clinical practice, and to discuss the problems encountered in both intermittent and continuous infusion applications, in the light of the literature. |
| first_indexed | 2024-04-10T11:11:41Z |
| format | Article |
| id | doaj.art-d0872f83027145e2864eb187a18de9ef |
| institution | Directory Open Access Journal |
| issn | 1309-2545 |
| language | English |
| last_indexed | 2024-04-10T11:11:41Z |
| publishDate | 2021-12-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Türk Nöroloji Dergisi |
| spelling | doaj.art-d0872f83027145e2864eb187a18de9ef2023-02-15T16:19:02ZengGalenos YayineviTürk Nöroloji Dergisi1309-25452021-12-0127435836510.4274/tnd.2021.06706Apomorphine in the Treatment of Parkinson’s DiseaseSerhat Özkan0https://orcid.org/0000-0002-5874-5270Eskisehir Osmangazi University Faculty of Medicine, Department of Neurology, Eskisehir, TurkeyApomorphine is a dopamine agonist used in the treatment of some motor and non-motor complications during Parkinson’s disease, which could be administered as an intermittent or continuous infusion. Although apomorphine treatment has been shown to be effective on motor fluctuations and dyskinesias, there is no sufficient consensus regarding the administration of apomorphine test or infusion, and the management of the treatment. In this review, our aim is to create a “treatment management guideline,” which includes recommendations for the use of apomorphine in the clinical practice, and to discuss the problems encountered in both intermittent and continuous infusion applications, in the light of the literature.https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-06706&look4=apomorphineparkinson’s diseasetreatment |
| spellingShingle | Serhat Özkan Apomorphine in the Treatment of Parkinson’s Disease Türk Nöroloji Dergisi apomorphine parkinson’s disease treatment |
| title | Apomorphine in the Treatment of Parkinson’s Disease |
| title_full | Apomorphine in the Treatment of Parkinson’s Disease |
| title_fullStr | Apomorphine in the Treatment of Parkinson’s Disease |
| title_full_unstemmed | Apomorphine in the Treatment of Parkinson’s Disease |
| title_short | Apomorphine in the Treatment of Parkinson’s Disease |
| title_sort | apomorphine in the treatment of parkinson s disease |
| topic | apomorphine parkinson’s disease treatment |
| url | https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-06706&look4= |
| work_keys_str_mv | AT serhatozkan apomorphineinthetreatmentofparkinsonsdisease |